Stocks
Immunomedics (IMMU) EBITDA US GAAP (year values) |
|||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -45.3 | -57.9 | -146.8 | -249.1 | -321.0 | -259.6 | ||
| Changes by years, y/y, % | +30% | +28% | +154% | +70% | +29% | +55.9% | |||
Immunomedics. EBITDA US GAAP, bln rub
Immunomedics. EBITDA US GAAP, changes, %
Immunomedics. EBITDA US GAAP, sum by quarters, bln rub
Immunomedics (IMMU) EBITDA US GAAP (quarter values) |
||||||||
| 2019Q4 | 2020Q3 | 2020Q1 | 2020Q2 | 2020Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -90.5 | -78.5 | -78.5 | -51.3 | -51.3 | -259.6 | |
| Changes by years, y/y, % | -8% | 0% | -22% | -43% | ||||
| Changes by quarters, q/q, % | +6% | -13% | 0% | -35% | 0% | |||
